Jupiter Life Line Hospitals Limited has informed the Exchange regarding Appointment of Dr. Ankit Thakker as Joint Managing Director of the company w.e.f. July 11, 2025.
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jupiter Life Line Hospitals has announced the appointment of Dr. Ankit Thakker as Joint Managing Director and CEO for a period of five years, effective July 11, 2025, until July 10, 2030. The appointment is subject to shareholder approval at the upcoming Annual General Meeting. Dr. Thakker, who holds DIN 02874715, has been with the company since 2014 and was previously serving as Executive Director and CEO. He is a medical doctor with a Master's in Management from the London School of Economics and Political Science. He is the son of Dr. Ajay Thakker, indicating he is part of the promoter family. The decision was approved by the Board on May 9, 2025, based on the recommendation of the Nomination and Remuneration Committee.
This is a leadership continuity move with the existing CEO being elevated to Joint Managing Director, which provides stability and signals the promoter's long-term commitment to the company's growth. For shareholders, this formalizes the succession and leadership structure without any disruption to ongoing operations.